212 related articles for article (PubMed ID: 26815502)
21. Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Ge NJ; Shi ZY; Yu XH; Huang XJ; Wu YS; Chen YY; Zhang J; Yang YF
Asian Pac J Cancer Prev; 2015; 16(9):4103-7. PubMed ID: 25987094
[TBL] [Abstract][Full Text] [Related]
22. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
[TBL] [Abstract][Full Text] [Related]
23. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
24. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
25. U/G SNP rs111904020 in 3'UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population.
Fan Y; Qian X; Zhang C
Tumour Biol; 2016 Nov; 37(11):14629-14635. PubMed ID: 27619679
[TBL] [Abstract][Full Text] [Related]
26. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
[TBL] [Abstract][Full Text] [Related]
27. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
29. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
30. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
[TBL] [Abstract][Full Text] [Related]
32. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
[TBL] [Abstract][Full Text] [Related]
33. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
34. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
35. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
36. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
[TBL] [Abstract][Full Text] [Related]
37. High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation.
Cho HJ; Kim JK; Nam JS; Wang HJ; Lee JH; Kim BW; Kim SS; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
Clin Biochem; 2015 Nov; 48(16-17):1073-8. PubMed ID: 26129878
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
Hassan MM; Kaseb A; Etzel CJ; El-Serag H; Spitz MR; Chang P; Hale KS; Liu M; Rashid A; Shama M; Abbruzzese JL; Loyer EM; Kaur H; Hassabo HM; Vauthey JN; Wray CJ; Hassan BS; Patt YZ; Hawk E; Soliman KM; Li D
Mol Carcinog; 2013 Nov; 52 Suppl 1(0):E139-47. PubMed ID: 23776098
[TBL] [Abstract][Full Text] [Related]
39. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
40. A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma.
Zhang L; Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zhao XM
Oncotarget; 2016 Jan; 7(3):3587-98. PubMed ID: 26657296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
